Skip to main content
GFC Life Science Co., Ltd. logo

GFC Life Science Co., Ltd. — Investor Relations & Filings

Ticker · 388610 ISIN · KR7388610008 KO Manufacturing
Open in API
Filings indexed 131 across all filing types
Latest filing 2026-05-22 Director's Dealing
Country KR South Korea
Listing KO 388610

About GFC Life Science Co., Ltd.

https://gfcos.co.kr/

GFC Life Science Co., Ltd., established in 2002, is a biotechnology company focused on the research, development, and manufacturing of advanced materials. The company specializes in creating biomaterials, natural active molecules, and plant extracts for the cosmetics, food, and medical sectors. Its core expertise lies in developing functional cosmetic ingredients, with a research focus on human biotechnology and the skin microbiome. GFC Life Science also offers customized product development and operates a clinical research division to scientifically verify the safety and efficacy of cosmetic products and materials.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 85% confidence The document is a statutory report filed with Korean regulators (Financial Services Commission and Korea Exchange) detailing the director’s and major shareholder’s specific securities holdings, including share option exercises and resulting share positions. It is an insider trading/holding disclosure by an executive (임원), fitting the Director’s Dealing category.
2026-05-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a "주식등의 대량보유상황보고서(일반)" – a statutory report on large shareholding status filed under Korea’s Capital Market Act Article 147, detailing the number of shares held by the reporting person (and special related parties), changes due to option exercises, dates, and reasons. This aligns with Major Shareholding Notification: notifications of changes in significant share ownership levels (crossing thresholds).
2026-05-22 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 75% confidence The document is a short announcement detailing the date, time, location, and agenda for an upcoming corporate IR (investor relations) meeting. It does not include actual financial statements, presentation slides, or substantive investor presentation content—it merely notifies stakeholders of the event. As such, it is a general regulatory announcement/fallback filing rather than the actual Investor Presentation (IP) or a financial report. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-20 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 99% confidence The document is a Korean 분기보고서 (quarterly report) for the period 2026-01-01 to 2026-03-31 (Q1 of 2026). It contains detailed company overview, financial data (e.g., sales breakdown by segment), capital changes, share information, business activities, and substantive tables. It is not merely an announcement or a short notice but the full interim/quarterly report itself. Therefore, it should be classified as an Interim/Quarterly Report (IR). Q1 2026
2026-05-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 85% confidence The document is a Korean "주식등의 대량보유상황보고서" which is a large shareholding report under the Capital Markets Act, detailing the number of shares and changes in ownership by the major shareholder and related parties. This matches the definition of "Major Shareholding Notification" (Code: MRQ), notifying a significant share ownership change.
2026-04-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-04-10 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.